, Tracking Stock Market Picks
Enter Symbol:
Natus Medical Incorporated (BABY) [hlAlert]

up 327.61 %

Natus Medical Incorporated (BABY) rated Buy with price target $16 by UBS

Posted on: Friday,  Jan 9, 2009  10:25 AM ET by UBS

UBS rated Buy Natus Medical Incorporated (NASDAQ: BABY) on 01/09/2009, when the stock price was $9.67. Since
then, Natus Medical Incorporated has gained 327.61% as of 01/12/2016's recent price of $41.35.
If you would have followed this UBS's recommendation on BABY, you would have gained 327.61% of your investment in 2559 days.

Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/9/2009 10:25 AM Buy
9.67 16.00
as of 12/31/2009
1 Week up  2.39 %
1 Month up  15.76 %
3 Months down  -0.06 %
1 YTD up  59.46 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy